பங்குதாரர் ஆண்டு ஜநரல் சந்தித்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பங்குதாரர் ஆண்டு ஜநரல் சந்தித்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பங்குதாரர் ஆண்டு ஜநரல் சந்தித்தல் Today - Breaking & Trending Today

WAVESTONE: 2020/21 annual results: EBIT margin solid at 12.8% and strong cash flow generation

WAVESTONE: 2020/21 annual results: EBIT margin solid at 12.8% and strong cash flow generation
At its meeting of June 1, 2021, Wavestone s Supervisory Board approved the consolidated annual accounts as at March 31, 2021, which are summarized below. Auditing of the accounts is complete and the auditors are in the process of issuing their report.
Consolidated audited data at 3/31 (in €m)
2020/21
Operating income
Income tax expenses
Net margin
A strong end-of-year position for 2020/21: decline in annual revenue limited to -1%
At the end of the 2020/21 fiscal year, Wavestone s consolidated revenue stood at €417.6m.
Buoyed by a progressive improvement in business activity in H2, the company recorded a limited decline in annual revenue of -1% (identical decline at constant scope and exchange rates). This trend demonstrates the firm s solid outperformance of the market, in a consulting sector where revenue fell by about 13% worldwide over 2020 (sour ....

United States , France General , Nicolas Bouchez , Syntec Conseil , Mathieu Omnes , Pascal Imbert , Everest Group , Source Global Research , Supervisory Board , Management Board , Annual General Meeting , Shareholder Annual General Meeting , Positive Way , ஒன்றுபட்டது மாநிலங்களில் , பிரான்ஸ் ஜநரல் , எவரெஸ்ட் குழு , மூல உலகளாவிய ஆராய்ச்சி , மேற்பார்வை பலகை , மேலாண்மை பலகை , ஆண்டு ஜநரல் சந்தித்தல் , பங்குதாரர் ஆண்டு ஜநரல் சந்தித்தல் , பாஸிடிவ் வழி ,

Valbiotis: Largely Successful Capital Increase Through a Private Placement Totaling 15 Million Euros

Valbiotis: Largely Successful Capital Increase Through a Private Placement Totaling 15 Million Euros
Gross amount of the capital increase: 15 M€.
Market capitalization: 79 M€, after issuance of 1,930,000 New Shares at a unit price of 7.80 €, representing a 5.1% discount.
Funding secured until first semester 2024.
A sustainably secure financial situation that does not include milestones payments and potential royalties resulting from the partnership with Nestlé Health Science as well as additional revenues associated with the signing of any new partnership.
Regulatory News:
Valbiotis (Paris:ALVAL) (FR0013254851 ALVAL, PEA-PME eligible), a Research Development company committed to scientific innovation for the treatment and prevention of metabolic diseases, today announces the large successful capital increase through a private placement open to certain categories of beneficiaries launched the previous day and achieved using an accelerated bookbui ....

United States , United Kingdom , Djanka Investissement , European Regional Development Fund , Young Innovative Company , Health Science , European Union , Research Development , Innovative Company , Shareholder Annual General Meeting , Supervisory Board , Euronext Growth Paris , General Regulation , General Regulations , French Financial Markets Regulator , Securities Act , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஐரோப்பிய பிராந்திய வளர்ச்சி நிதி , இளம் புதுமையானது நிறுவனம் , ஆரோக்கியம் அறிவியல் , ஐரோப்பிய தொழிற்சங்கம் , ஆராய்ச்சி வளர்ச்சி , புதுமையானது நிறுவனம் , பங்குதாரர் ஆண்டு ஜநரல் சந்தித்தல் , மேற்பார்வை பலகை ,

Valbiotis Launches a Capital Increase Through a Private Placement

Valbiotis Launches a Capital Increase Through a Private Placement
Regulatory News:
Valbiotis (Paris:ALVAL) (FR0013254851 ALVAL, PEA-PME eligible), a Research Development company committed to scientific innovation for preventing and combating metabolic diseases, today announces the launch of a capital increase within the context of a private placement through an accelerated bookbuilding process for an amount of approximately 12 million euros. This capital increase, with the removal of shareholders preferential subscription rights in favor of a category of persons, will be reserved exclusively for qualified investors as referred to in article 2(e) of Regulation (EU) 2017/1129 of June 14, 2017.
Reasons for the offer
The net proceeds of the capital increase are intended primarily to finance the acceleration of the development of TOTUM•854 (prevention of arterial hypertension) with the launch of three clinical trials at the end of this year including a Phase II/II ....

United States , United Kingdom , European Regional Development Fund , European Parliament , Health Science , Research Development , French Financial Markets Authority , Young Innovative Company , European Union , Valbiotis The Company , Innovative Company , Shareholder Annual General Meeting , European Economic Area , Securities Act , Invest Securities , Global Coordinators , French Financial Markets Regulator , General Regulations , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஐரோப்பிய பிராந்திய வளர்ச்சி நிதி , ஐரோப்பிய பாராளுமன்றம் , ஆரோக்கியம் அறிவியல் , ஆராய்ச்சி வளர்ச்சி , பிரஞ்சு நிதி சந்தைகள் அதிகாரம் , இளம் புதுமையானது நிறுவனம் ,

Carmila: 2020 Annual Results

Carmila: 2020 Annual Results
Regulatory News:
In a year characterised by the health crisis and attendant business restrictions, Carmila s (Paris:CARM) core business was resilient and its financial structure solid:
Encouraging performances on business resumption during the different reopening phases
Stable rental base, down just 0.5% versus 2019
Dynamic leasing activity
EPRA Net Tangible Assets of €24.72 per share
Loan-to-value ratio (including transfer taxes) at 37.0%
Recurring earnings of €167.6 million, down 24.7% versus 2019, at €1.20 per share
Marie Cheval, Chairman and Chief Executive Officer of Carmila commented
: In an unprecedented health context for Carmila and for the entire industry, this has been a very demanding year. The multiple challenges brought about by the crisis have served to underline the particular strengths of Carmila s shopping centres: rooted in local regions, backed by the partnership with Carrefour, enga ....

France General , Provence Alpes Côd Azur , Flins Aubergenville , Florence Lonis , Marie Cheval , Europe Calais Coquelles , Health Beauty , Group French , Carmila Retail Development , Toulouse Lab , Foot Locker , Digital Native Group , Morgan Lavielle Communications , Tower Company Lou , Regulatory News , Tangible Assets , Chief Executive Officer , Food Restaurants , Gifts Leisure , Specialty Leasing , Pop Up Stores , Google My Business , Net Promoter Score , Nice Lingosti , Nantes Beaujoire , Centros Ideal ,

WAVESTONE: Resumption of Wavestone's dividend payment policy for the 2020/21 fiscal year

WAVESTONE: Resumption of Wavestone s dividend payment policy for the 2020/21 fiscal year
At its meeting on January 29, 2021, Wavestone s Supervisory Board approved the Management Board s proposal to resume the company s dividend payment policy. The decision was made in light of the firm s improved performance and the resilience of the outlook in the consulting market, despite the health situation.
A resolution to this effect will therefore be proposed at the Shareholders Annual General Meeting on July 27, 2021, which will approve the accounts for the 2020/21 fiscal year. The level of the proposed dividend will be determined in relation to the accounts closed on March 31, 2021.
As a reminder, Wavestone took the decision to exceptionally suspend its dividend payment policy in the context of the Covid-19 crisis. As a result, no dividend was paid for the 2019/20 fiscal year. ....

Nicolas Bouchez , Mathieu Omnes , Pascal Imbert , Supervisory Board , Management Board , Shareholder Annual General Meeting , Positive Way , Euronext Paris , Great Place , மேற்பார்வை பலகை , மேலாண்மை பலகை , பங்குதாரர் ஆண்டு ஜநரல் சந்தித்தல் , பாஸிடிவ் வழி , நன்று இடம் ,